Bisaro Paul

CIK 000123725310 companiesSALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001237253

Recent Transactions

50 trades

Award
MYRIAD GENETICS INC$MYGN
Common Stock
2026-06-04+59,701→ 157,142 total
Exercise/Conversion
Keenova Therapeutics plc
Ordinary Shares
2026-06-02+2,685→ 6,863 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2026-06-02−619→ 6,244 total
Disposition to Issuer
Keenova Therapeutics plc
Restricted Stock Units
2026-06-02−2,197→ 45,028 total
Exercise/Conversion
Keenova Therapeutics plc
Restricted Stock Units
2026-06-02−2,685→ 42,343 total
Purchase
MYRIAD GENETICS INC$MYGN
Common Stock
2026-05-14$3.69/sh+7,500→ 97,441 total
Purchase
Zoetis Inc.$ZTS
Common Stock
2026-05-13$75.88/sh+2,000→ 27,862 total
Award
Keenova Therapeutics plc
Restricted Stock Units
2026-02-23+3,984→ 47,225 total
Exercise/Conversion
Zoetis Inc.$ZTS
Common Stock
2026-02-19+1,619→ 25,862 total
Exercise/Conversion
Zoetis Inc.$ZTS
Restricted Stock Unit
2026-02-19−1,619.333→ 0 total
Award
Zoetis Inc.$ZTS
Restricted Stock Unit
2026-02-18+1,936→ 1,936 total
Exercise/Conversion
Keenova Therapeutics plc
Ordinary Shares
2026-01-01+3,014→ 5,032 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2026-01-01−854→ 4,178 total
Disposition to Issuer
Keenova Therapeutics plc
Restricted Stock Units
2026-01-01−2,466→ 46,255 total
Exercise/Conversion
Keenova Therapeutics plc
Restricted Stock Units
2026-01-01−3,014→ 43,241 total
Award
Keenova Therapeutics plc
Restricted Stock Units
2025-08-14+4,062→ 40,538 total
Award
Keenova Therapeutics plc
Restricted Stock Units
2025-07-31+27,357→ 36,476 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2025-06-05+49,796→ 89,941 total
Award
Zoetis Inc.$ZTS
Restricted Stock Unit
2025-02-19+1,596→ 1,596 total
Exercise/Conversion
Zoetis Inc.$ZTS
Common Stock
2025-02-08+1,225→ 24,243 total
Exercise/Conversion
Zoetis Inc.$ZTS
Restricted Stock Unit
2025-02-08−1,225.402→ 0 total
Exercise/Conversion
Zoetis Inc.$ZTS
Restricted Stock Unit
2025-02-06−1,236.213→ 0 total
Exercise/Conversion
Zoetis Inc.$ZTS
Common Stock
2025-02-06+1,236→ 23,018 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2025-01-01−489→ 2,018 total
Exercise/Conversion
Keenova Therapeutics plc
Ordinary Shares
2025-01-01+2,507→ 2,507 total
Exercise/Conversion
Keenova Therapeutics plc
Restricted Stock Units
2025-01-01−2,507→ 9,119 total
Disposition to Issuer
Keenova Therapeutics plc
Restricted Stock Units
2025-01-01−2,052→ 11,626 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2024-06-06+15,695→ 40,145 total
Award
Keenova Therapeutics plc
Restricted Stock Units
2024-02-19−13,678→ 13,678 total
Exercise/Conversion
Zoetis Inc.$ZTS
Restricted Stock Unit
2024-02-10−1,463.394→ 1,212.305 total
Exercise/Conversion
Zoetis Inc.$ZTS
Common Stock
2024-02-10+1,463→ 21,782 total
Exercise/Conversion
Zoetis Inc.$ZTS
Common Stock
2024-02-08+1,493→ 20,319 total
Exercise/Conversion
Zoetis Inc.$ZTS
Restricted Stock Unit
2024-02-08−1,493.265→ 0 total
Award
Zoetis Inc.$ZTS
Restricted Stock Unit
2024-02-06+1,223→ 1,223 total
Disposition to Issuer
Keenova Therapeutics plc
Ordinary Shares
2023-11-14−32,048→ 0 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2023-06-16$1.28/sh−3,689→ 71,131 total
Disposition to Issuer
Keenova Therapeutics plc
Ordinary Shares
2023-06-16−39,083→ 32,048 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2023-06-01+7,575→ 24,450 total
Purchase
Keenova Therapeutics plc
Ordinary Shares
2023-03-14$8.47/sh+5,000→ 74,820 total
Exercise/Conversion
Zoetis Inc.$ZTS
Common Stock
2023-02-11+1,626→ 18,826 total
Exercise/Conversion
Zoetis Inc.$ZTS
Restricted Stock Unit
2023-02-11−1,626.844→ 2,651.93 total
Award
Zoetis Inc.$ZTS
Restricted Stock Unit
2023-02-08+1,480→ 1,480 total
Award
Keenova Therapeutics plc
Ordinary Shares
2023-01-03+39,083→ 69,820 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2022-10-31+16,875→ 16,875 total
Award
TherapeuticsMD, Inc.$TXMD
Restricted Stock Units
2022-09-29+5,000→ 5,000 total
Exercise/Conversion
TherapeuticsMD, Inc.$TXMD
Common Stock
2022-08-18+1,984→ 5,922 total
Exercise/Conversion
TherapeuticsMD, Inc.$TXMD
Restricted Stock Units
2022-08-18−1,984→ 0 total
Disposition to Issuer
Keenova Therapeutics plc
Restricted Stock Units
2022-08-16−44,354→ 30,737 total
Award
Keenova Therapeutics plc
Restricted Stock Units
2022-07-01+75,091→ 75,091 total
Exercise/Conversion
Zoetis Inc.$ZTS
Common Stock
2022-02-12+2,673→ 17,200 total

Bisaro Paul

Recent Transactions

Companies

Recent Filings

Address